PCN521 THE FINANCIAL IMPACT OF AFATINIB REIMBURSEMENT FOR EPIDERMAL GROWTH FACTOR RECEPTOR MUTATION-POSITIVE NON-SMALL CELL LUNG CANCER: THE REAL-WORLD EVIDENCE IN TAIWAN
Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.713
https://www.valueinhealthjournal.com/article/S1098-3015(19)33091-8/fulltext
Section Title :
Section Order :
10625
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33091-8&doi=10.1016/j.jval.2019.09.713